Detalhe da pesquisa
1.
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto.
Ann Oncol
; 29(12): 2341-2347, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30335131